Class Action

Advil, Tylenol, DayQuil, NyQuil, TheraFlu, Sudafed, and Other Cold and Flu Medicines

Class Action

Advil, Tylenol, DayQuil, NyQuil, TheraFlu, Sudafed, and Other Cold and Flu Medicines


Case Name (Date)

Chamberlain et al. v. Johnson & Johnson Consumer Inc., RB Health LLC, GlaxoSmithKline Consumer Healthcare Holdings (US), LLC
23-cv-4435, E.D. Penn.
(Nov. 2023)

Travis et al. v. Procter & Gamble Co., Kenvue, Inc., McNeil Consumer Healthcare, Reckitt & Benckiser LLC and GlaxoSmithKline, LLC
23-cv-607, S.D. Ohio
(Sept. 2023)


Product/Service

Advil, Tylenol, DayQuil, NyQuil, TheraFlu, Sudafed, and other cold and flu medicines


Allegations

Falsely marketing that medicines are decongestants when the active ingredient (phenylephrine) is not an effective decongestant


Status

Pending



Class-Action Tracker


The Latest

Filters

Ad Watchdog TINA.org Petitions FTC for Made in USA Rule

Press Release

Ad Watchdog TINA.org Petitions FTC for Made in USA Rule

MADISON, CONN. August 22, 2019– Consumer advocacy organization, truthinadvertising.org (TINA.org), filed a formal petition today requesting that the Federal Trade Commission (FTC) use its rulemaking authority to expand its enforcement…


Show More